Pharmaceutical Agents and Pregnancy in Urology Practice

Urologic Clinics of North America

Volumn 34, Issue 1, 2007, Pages 27-33

  Shrim, Alon ^a   Garcia Bournissen, Facundo ^a   Koren, Gideon ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; NITROFURANTOIN; NITROUS OXIDE; NON PRESCRIPTION DRUG; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TERATOGENIC AGENT;

ABORTION; ANTIBIOTIC RESISTANCE; ARTHROPATHY; BACTERIURIA; CLINICAL PRACTICE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CYSTITIS; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG HALF LIFE; DRUG INFORMATION; DRUG OVERDOSE; DRUG SAFETY; DRUG URINE LEVEL; FETUS DISEASE; FETUS DISTRESS; FETUS OUTCOME; FETUS RISK; GENERAL ANESTHESIA; HEALTH PRACTITIONER; HEART VENTRICLE SEPTUM DEFECT; HEMOLYTIC ANEMIA; HUMAN; INFECTION PREVENTION; LOW BIRTH WEIGHT; MUSCULOSKELETAL DISEASE; MUTAGENESIS; NONHUMAN; PATIENT COUNSELING; POSTOPERATIVE INFECTION; PREGNANCY; PREGNANCY OUTCOME; PREMATURITY; PRENATAL EXPOSURE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; SAFETY; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; SPONTANEOUS ABORTION; SURGICAL TECHNIQUE; TENDINITIS; TERATOGENICITY; URINARY TRACT DISEASE; URINARY TRACT INFECTION; UROGENITAL TRACT INFECTION; UROLOGY;

FEMALE; FETUS; FLUOROQUINOLONES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; UROLOGIC DISEASES; UROLOGIC SURGICAL PROCEDURES;

EID: 33751532390     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2006.10.004     Document Type: Review

References (39)

1. Sophocles Jr. A.M., and Brozovich E.M. Birth control failure among patients with unwanted pregnancies: 1982-1984. J Fam Pract 22 1 (1986) 45-48
2. Suchanek P., Nagy V., and Lukacin S. [Effect of acute urological complications on the course of pregnancy.]. Ceska Gynekol 68 5 (2003) 336-340
3. Leveno K.J., Cunningham F.G., and Grant N.F. William's Obstetrics. 22nd edition (2005), McGraw-Hill, Columbus (OH)
4. Butler E.L., Cox S.M., Eberts E.G., et al. Symptomatic nephrolithiasis complicating pregnancy. Obstet Gynecol 96 5 Pt 1 (2000) 753-756
5. Lewis D.F., Robichaux III A.G., Jaekle R.K., et al. Urolithiasis in pregnancy. Diagnosis, management and pregnancy outcome. J Reprod Med 48 1 (2003) 28-32
6. Le J., Briggs G.G., McKeown A., et al. Urinary tract infections during pregnancy. Ann Pharmacother 38 10 (2004) 1692-1701
7. Mazzulli T. Resistance trends in urinary tract pathogens and impact on management. J Urol 168 4 Pt 2 (2002) 1720-1722
8. Procter & Gamble Pharmaceuticals. Macrodantin: product monograph. Cinncinnati (OH): Procter & Gamble Pharmaceuticals 2001.
9. Briggs G.G. Drugs in pregnancy and lactation. 7th edition (2005), Lippincott, Williams & Wilkins, Philadelphia
10. Czeizel A.E., Rockenbauer M., Sorensen H.T., et al. Nitrofurantoin and congenital abnormalities. Eur J Obstet Gynecol Reprod Biol 95 1 (2001) 119-126
11. Hailey F.J., Fort H., Williams J.C., et al. Foetal safety of nitrofurantoin macrocrystals therapy during pregnancy: a retrospective analysis. J Int Med Res 11 6 (1983) 364-369
12. Lenke R.R., VanDorsten J.P., and Schifrin B.S. Pyelonephritis in pregnancy: a prospective randomized trial to prevent recurrent disease evaluating suppressive therapy with nitrofurantoin and close surveillance. Am J Obstet Gynecol 146 8 (1983) 953-957
13. Ben D.S., Einarson T., Ben D.Y., et al. The safety of nitrofurantoin during the first trimester of pregnancy: meta-analysis. Fundam Clin Pharmacol 9 5 (1995) 503-507
14. Bruel H., Guillemant V., Saladin-Thiron C., et al. [Hemolytic anemia in a newborn after maternal treatment with nitrofurantoin at the end of pregnancy.]. Arch Pediatr 7 7 (2000) 745-747
15. Gait J.E. Hemolytic reactions to nitrofurantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and practice. DICP 24 12 (1990) 1210-1213
16. Lipsky B.A., and Baker C.A. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis 28 2 (1999) 352-364
17. Schaefer C., Moura-Elefant E., Vial T., et al. Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS). Eur J Obstet Gynecol Reprod Biol 69 2 (1996) 83-89
18. Amin M. Antibacterial prophylaxis in urology: a review. Am J Med 92 4A (1992) 114S-117S
19. Giamarellou H., Kolokythas E., Petrikkos G., et al. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 87 5A (1989) 49S-51S
20. Aramayona J.J., Garcia M.A., Fraile L.J., et al. Placental transfer of enrofloxacin and ciprofloxacin in rabbits. Am J Vet Res 55 9 (1994) 1313-1318
21. von Keutz E., Ruhl-Fehlert C., Drommer W., et al. Effects of ciprofloxacin on joint cartilage in immature dogs immediately after dosing and after a 5-month treatment-free period. Arch Toxicol 78 7 (2004) 418-424
22. Linseman D.A., Hampton L.A., and Branstetter D.G. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fundam Appl Toxicol 28 1 (1995) 59-64
23. Alfaham M., Holt M.E., and Goodchild M.C. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin. Br Med J (Clin Res Ed) 295 6600 (1987) 699
24. Schacht P., Arcieri G., and Hullmann R. Safety of oral ciprofloxacin. An update based on clinical trial results. Am J Med 87 5A (1989) 98S-102S
25. Berkovitch M., Pastuszak A., Gazarian M., et al. Safety of the new quinolones in pregnancy. Obstet Gynecol 84 4 (1994) 535-538
26. Loebstein R., Addis A., Ho E., et al. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 42 6 (1998) 1336-1339
27. Brodsky J.B., Cohen E.N., Brown Jr. B.W., et al. Surgery during pregnancy and fetal outcome. Am J Obstet Gynecol 138 8 (1980) 1165-1167
28. Jenkins T.M., Mackey S.F., Benzoni E.M., et al. Non-obstetric surgery during gestation: risk factors for lower birthweight. Aust N Z J Obstet Gynaecol 43 1 (2003) 27-31
29. Mazze R.I., and Kallen B. Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol 161 5 (1989) 1178-1185
30. Kuczkowski K.M. The safety of anaesthetics in pregnant women. Expert Opin Drug Saf 5 2 (2006) 251-264
31. Stepp K.J., Sauchak, O'Malley D.M., et al. Risk factors for adverse outcomes after intraabdominal surgery during pregnancy. Obstet Gynecol 99 (2002) 23S
32. Czeizel A.E., Pataki T., and Rockenbauer M. Reproductive outcome after exposure to surgery under anesthesia during pregnancy. Arch Gynecol Obstet 261 4 (1998) 193-199
33. Kallen B., and Mazze R.I. Neural tube defects and first trimester operations. Teratology 41 6 (1990) 717-720
34. Cohen-Kerem R., Railton C., Oren D., et al. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg 190 3 (2005) 467-473
35. Lachman E., Schienfeld A., Voss E., et al. Pregnancy and laparoscopic surgery. J Am Assoc Gynecol Laparosc 6 3 (1999) 347-351
36. Steinbrook R.A., and Bhavani-Shankar K. Hemodynamics during laparoscopic surgery in pregnancy. Anesth Analg 93 6 (2001) 1570-1571
37. Wahba R.W., Beique F., and Kleiman S.J. Cardiopulmonary function and laparoscopic cholecystectomy. Can J Anaesth 42 1 (1995) 51-63
38. Reedy M.B., Kallen B., and Kuehl T.J. Laparoscopy during pregnancy: a study of five fetal outcome parameters with use of the Swedish Health Registry. Am J Obstet Gynecol 177 3 (1997) 673-679
39. Oelsner G., Stockheim D., Soriano D., et al. Pregnancy outcome after laparoscopy or laparotomy in pregnancy. J Am Assoc Gynecol Laparosc 10 2 (2003) 200-204